Key result
Withdrawal of anti-TNF-alpha therapy highlights the need to evaluate clinical readiness for biological therapy cycling.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Pugliese et al. (2021) studied this question. Withdrawal of anti-TNF-alpha therapy highlights the need to evaluate clinical readiness for biological therapy cycling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: